Skip to main content
. 2021 Apr 23;36(3):1868–1875. doi: 10.1007/s00464-021-08466-2

Fig. 1.

Fig. 1

Survival analysis by different therapeutic strategy in the ECETC set. A KM curves for overall survival with abstracted number at risk displayed (HR 2.43 with 95%CI 0.78 to 7.56, P = 0.226). B KM curves for relapse-free survival with abstracted number at risk displayed (HR 1.04, 95% CI 0.41 to 2.60, P = 0.938)